[Rhabdomysarcoma and combined treatment in oral and maxillofacial regions].
To study the treatment outcome of rhabdomysarcoma(RMS). 74 cases of RMS with definite pathologic diagnosis treated in our department during the past 20 years were investigated. The relationship between the therapy and prognosis was analyzed. 52 cases among the 74 patients received different surgical treatment and post-operative radiotherapy. 22 cases received radiotherapy or chemoradiotherapy without surgical treatment. The survival rates demonstrated great differences depending on the different clinical stages and therapy. The combined therapy including radiotherapy after surgical treatment may increase 5-year survival rate.